Related Experiment Video
Updated: Jun 18, 2026
08:33
Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
Published on: January 19, 2015
Multivalent binding oligomers inhibit HIV Tat-TAR interaction critical for viral replication
Deyun Wang1, Jaclyn Iera, Heather Baker
1Laboratory of Bioorganic Chemistry, NIDDK, NIH, DHHS, Bethesda, MD 20892, USA. appellad@niddk.nih.gov
Bioorganic & Medicinal Chemistry Letters
|November 10, 2009
Summary
Researchers developed novel multivalent binding oligomers (MBOs) to target RNA structures. These MBOs effectively inhibit the Tat-TAR protein-RNA interaction crucial for HIV replication, showing promise for future antiviral therapies.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Virology
Background:
- Targeting RNA structures presents a promising avenue for therapeutic intervention.
- The Tat-TAR protein-RNA complex is essential for HIV replication and represents a key drug target.
Purpose of the Study:
- To develop a novel scaffold for targeting RNA structures.
- To design and evaluate multivalent binding oligomers (MBOs) as inhibitors of the HIV Tat-TAR complex.
Main Methods:
- Design and synthesis of multivalent binding oligomers (MBOs).
- In vitro binding assays to assess inhibition of Tat-TAR complex formation.
- Cell-based assays to evaluate MBO efficacy in a biological context.
- Antiviral studies to determine the in vivo effectiveness of MBOs.
Main Results:
- Optimal MBOs were identified that inhibit Tat-TAR binding at low micromolar concentrations.
- In vitro and cell-based assays demonstrated significant inhibition of the target interaction.
- Antiviral studies confirmed the efficacy observed in earlier assays.
Conclusions:
- Multivalent binding oligomers (MBOs) represent a viable strategy for targeting RNA structures.
- MBOs show potential as a new class of antiviral agents, specifically for HIV.
- This scaffold provides a framework for developing future RNA-targeting therapeutics.
Related Concept Videos
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:52Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...